ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: It may also be a potential therapeutic target for treatment.   33  In Table 1, a list of miRs undergoing altered expression in CML has been presented and Figure 2 presented BCR-ABL associated miRs.